Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jin Soo Lee, M.D.
National Cancer Center, Korea
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Cancer Center, Korea
Goyang-si, Gyenggi-do, South Korea
Bin Hwangbo, M.D.Byung-Ho Nam, Ph.D.Geon Kook Lee, M.D.Hee Seok Lee, M.D.Heung Tae Kim, M.D.Hong Ryull Pyo, M.D.Jae-ill Zo, M.D.Ji-Youn Han, M.D.Jin Soo Lee, M.D.Kun young Lim, M.D.Kwan Ho Cho, M.D.Kyong-Ah Yoon, PH.D.Tak Yun, M.D.Young Ho Yun, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2008
- Primary completion
- 31 Mar 2015
- Completion
- 31 Mar 2015
- Last update posted
- 7 Nov 2011
- Registered enrollment
- 212
- Registry id
- NCT00620269
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.